Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Payables (2021 - 2025)

Historic Payables for Biote (BTMD) over the last 5 years, with Q3 2025 value amounting to $4.4 million.

  • Biote's Payables fell 34.29% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 34.29%. This contributed to the annual value of $5.8 million for FY2024, which is 3990.37% up from last year.
  • Latest data reveals that Biote reported Payables of $4.4 million as of Q3 2025, which was down 34.29% from $3.9 million recorded in Q2 2025.
  • In the past 5 years, Biote's Payables registered a high of $9.2 million during Q2 2022, and its lowest value of $558.0 during Q1 2021.
  • Its 5-year average for Payables is $4.7 million, with a median of $4.4 million in 2025.
  • Its Payables has fluctuated over the past 5 years, first soared by 6721594.98% in 2022, then crashed by 3331.61% in 2025.
  • Over the past 5 years, Biote's Payables (Quarter) stood at $4.3 million in 2021, then dropped by 5.45% to $4.1 million in 2022, then rose by 1.05% to $4.2 million in 2023, then skyrocketed by 39.9% to $5.8 million in 2024, then decreased by 25.01% to $4.4 million in 2025.
  • Its Payables stands at $4.4 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.3 million for Q1 2025.